공시 • Apr 25
Charles & Colvard, Ltd.(OTCPK:CTHR) dropped from NASDAQ Composite Index Charles & Colvard, Ltd. has been dropped from the Nasdaq Composite Index 공시 • Apr 23
Charles & Colvard Announces Delisting from Nasdaq Charles & Colvard, Ltd. announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC (“Nasdaq”), informing the Company that Nasdaq determined to suspend trading and delist the Company’s common stock (the “Common Stock”) from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a careful review of numerous factors, including the potential for limiting the significant costs associated with remaining listed on Nasdaq and complying with Nasdaq listing standards. Nasdaq is expected to file a Form 25-NSE (Notification of Removal from Listing) with the Securities and Exchange Commission relating to the delisting of the Common Stock. Suspension of trading of the Common Stock will occur at the opening of business on April 25, 2025. Following the delisting, the Company expects that the Common Stock will be quoted on the OTC Experts Market. No assurances can be provided, however, that a trading market in the Common Stock in any over-the-counter market will be maintained. 공시 • Mar 04
Charles & Colvard Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q Charles & Colvard, Ltd. announced that on February 25, 2025, it received an expected notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) stating that the Company continues to not be in compliance with Nasdaq Listing Rule 5250(c)(1) (the ‘Listing Rule’), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2024. Nasdaq previously accepted the Company’s plan to regain compliance with the Listing Rule and granted the Company until April 14, 2025 to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 and Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024. Nasdaq has informed the Company that it must submit an update to its original plan of compliance no later than March 12, 2025 and that any additional exception to allow the Company to regain compliance with all delinquent filings will be limited to April 14, 2025. The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. The Company is working diligently to complete its delinquent periodic reports as promptly as practicable and regain compliance with the Listing Rule. 공시 • Feb 19
Charles & Colvard, Ltd. announced delayed 10-Q filing On 02/18/2025, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Jan 25
Charles & Colvard, Ltd. Announces the Resignation of Benedetta Casamento from the Board of Directors On January 20, 2025, Benedetta Casamento resigned from the Board of Directors of Charles & Colvard, Ltd. Her resignation from the Board was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. 공시 • Nov 28
Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq On November 21, 2024, Charles & Colvard, Ltd. (the Company") received a notice (the Notice") from the Listing Qualifications Department of the Nasdaq Stock Market (Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarter ended September 30, 2024 (the Form 10-Q"), and because the Company remains delinquent in filing its Form 10-K for the fiscal year ended June 30, 2024 (the Form 10-K"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Listing Rule") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the SEC"). The Form 10-Q was due on November 14, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on November 15, 2024. The Notice states that the Company has until December 17, 2024, to regain compliance with the Listing Rule or to submit a plan to regain compliance with the Listing Rule (the Plan"). If Nasdaq accepts the Company's Plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025, to file its Form 10-K and Form 10-Q to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Company is working diligently to complete its Form 10-K and Form 10-Q and plans to file its Form 10-K and Form 10-Q as promptly as practicable to regain compliance with the Listing Rule. 공시 • Nov 16
Charles & Colvard, Ltd. announced delayed 10-Q filing On 11/15/2024, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Oct 25
Charles & Colvard Receives Non-Compliance Letter from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1) Charles & Colvard, Ltd. (‘Charles & Colvard’ or the ‘Company’) announced that on October 18, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (‘Nasdaq’) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the ‘Listing Rule’), as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the ‘Form 10-K’), with the Securities and Exchange Commission (the ‘SEC’). The Form 10-K was due on September 30, 2024. The Company filed a Notification of Late Filing on Form 12b-25 with the SEC on October 1, 2024. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days, or until December 17, 2024, to regain compliance with the Listing Rule or to submit to Nasdaq a plan to regain compliance with the Listing Rule (the ‘Plan’). If Nasdaq accepts the Company's Plan, then Nasdaq may grant the Company up to 180 calendar days from the Form 10-K filing due date, or until April 14, 2025 to regain compliance. If Nasdaq does not accept the Company's Plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Company is working diligently to complete its Form 10-K and plans to file its Form 10-K as promptly as practicable to regain compliance with the Listing Rule. 공시 • Oct 02
Charles & Colvard, Ltd. announced delayed annual 10-K filing On 10/01/2024, Charles & Colvard, Ltd. announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • May 16
Charles & Colvard Approves 1-for-10 Reverse Split to Bring it into Compliance with Nasdaq's Minimum Bid Price Requirement for Continued Listing Charles & Colvard, Ltd. (the ‘Company’) announced that the company's board of directors has approved a one-for-ten (1:10) reverse split of the Company's common stock, no par value per share (the ‘Reverse Stock Split’), to be effective as of 12:01 a.m. Eastern Time on May 17, 2024 (the ‘Effective Date’). The Reverse Stock Split is intended to bring the Company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing. The Company expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on May 17, 2024 with a new CUSIP number of 159765205. The ticker symbol for the Company stock will remain ‘CTHR.’ The Company's shareholders at a special meeting held on May 7, 2024, approved a proposal to amend the Company's Restated Articles of Incorporation to effect a Reverse Stock Split at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board of Directors in its sole discretion. Reported Earnings • May 03
Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.28 loss in 3Q 2023) Third quarter 2024 results: US$0.12 loss per share (improved from US$0.28 loss in 3Q 2023). Revenue: US$5.26m (down 21% from 3Q 2023). Net loss: US$3.63m (loss narrowed 57% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. 공시 • Apr 24
Charles & Colvard, Ltd. to Report Q3, 2024 Results on May 02, 2024 Charles & Colvard, Ltd. announced that they will report Q3, 2024 results After-Market on May 02, 2024 New Risk • Apr 04
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.16m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.9m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (€9.16m market cap, or US$9.95m). Reported Earnings • Feb 14
Second quarter 2024 earnings released: US$0.094 loss per share (vs US$0.034 loss in 2Q 2023) Second quarter 2024 results: US$0.094 loss per share (further deteriorated from US$0.034 loss in 2Q 2023). Revenue: US$7.91m (down 24% from 2Q 2023). Net loss: US$2.87m (loss widened 175% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 55 percentage points per year, which is a significant difference in performance. 공시 • Feb 07
Charles & Colvard, Ltd. to Report Q2, 2024 Results on Feb 13, 2024 Charles & Colvard, Ltd. announced that they will report Q2, 2024 results After-Market on Feb 13, 2024 Board Change • Dec 28
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. President, CEO & Director Don O'Connell was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Dec 15
Charles & Colvard Receives Notification Letter from Nasdaq Regarding Eligible for an Additional 180-Day Grace Period, or Until June 10, 2024 to Regain Compliance with the Minimum Bid Price Requirement As previously disclosed, on June 12, 2023, Charles & Colvard, Ltd. (the ‘Company’) received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market had closed below $1.00 per share for 30 consecutive business days (the ‘Minimum Bid Price Requirement’). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had 180 calendar days, or until December 11, 2023, to regain compliance with the Minimum Bid Price Requirement. On December 12, 2023 the Company received a notification letter from Nasdaq’s Listing Qualifications Department indicating that, while the Company has not regained compliance with the Minimum Bid Price Requirement, it is eligible for an additional 180-day grace period, or until June 10, 2024, to regain compliance with the Minimum Bid Price Requirement (the ‘December Notice’). To regain compliance, any time before June 10, 2024, the bid price of the Company’s common stock must close at a $1.00 per share or more for a minimum of 10 consecutive business days. Nasdaq’s determination to grant an additional 180-day grace period is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on the Company’s written notice to Nasdaq on December 11, 2023 of its intention to cure the deficiency during the additional 180 calendar day compliance period, which compliance could be achieved by effecting a reverse stock split, if necessary. If the Company does not regain compliance by June 10, 2024, the Company expects that Nasdaq will provide written notification that the Company’s common stock will be delisted. At that time, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. The December Notice has no effect on the listing or trading of the Company’s common stock at this time. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement. 공시 • Nov 01
Charles & Colvard, Ltd. to Report Q1, 2024 Results on Nov 09, 2023 Charles & Colvard, Ltd. announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023 공시 • Oct 28
Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023 Charles & Colvard, Ltd., Annual General Meeting, Dec 14, 2023, at 10:00 US Eastern Standard Time. Location: 170 Southport Drive, Morrisville, Morrisville North Carolina United States Agenda: To consider elect five nominees described in the proxy statement to the Board of Directors; to consider ratify the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending June 30, 2024; to consider vote, on an advisory (nonbinding) basis, to approve executive compensation; and to consider transact such other business as may properly come before the meeting or any adjournment thereof. 공시 • Oct 11
Charles & Colvard, Ltd. to Report Q4, 2023 Results on Oct 12, 2023 Charles & Colvard, Ltd. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Oct 12, 2023 공시 • Oct 01
Charles & Colvard, Ltd. Provides Earnings Guidance for the Fiscal Year Ended June 30, 2023 Charles & Colvard, Ltd. provided earnings guidance for the fiscal year ended June 30, 2023. Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2023, the Company expects to report net sales decreased by 31% to $29.9 million for the fiscal year ended June 30, 2023 compared to net sales of $43.1 million for the fiscal year ended June 30, 2022. Consistent with the Company’s results for the first, second and third quarters of the fiscal year ended June 30, 2023, the Company will report a net loss for the fiscal year ended June 30, 2023 that is a significant change compared to net income of $2.4 million reported for the year ended June 30, 2022. Board Change • Jul 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. President, CEO & Director Don O'Connell was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 공시 • Jun 16
Charles & Colvard Receives Notification Letter from Nasdaq’s Listing Qualifications Department Indicating that the Company Is Not in Compliance with Nasdaq Listing Rule 5550(a)(2) On June 12, 2023, Charles & Colvard, Ltd. received a notification letter from Nasdaq’s Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company’s common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until December 11, 2023, to regain compliance with the minimum $1.00 bid price per share requirement. To regain compliance, any time before December 11, 2023, the bid price of the Company’s common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. On December 11, 2023, if the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except for the minimum bid price requirement), and the Company notifies Nasdaq of its intention to cure the deficiency, the Company may be provided with an additional 180 calendar day compliance period to regain compliance. If the Company is not eligible for an additional compliance period at that time, Nasdaq will provide the Company with written notification that its common stock will be subject to delisting. Upon such notice, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. There can be no assurance that, if the Company appeals Nasdaq’s determination, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements. Recent Insider Transactions • May 11
Insider recently bought €185k worth of stock On the 5th of May, Carlos Valadez bought around 215k shares on-market at roughly €0.86 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth €1.5m. Insiders have collectively bought €1.8m more in shares than they have sold in the last 12 months. Reported Earnings • May 07
Third quarter 2023 earnings released: US$0.28 loss per share (vs US$0.011 profit in 3Q 2022) Third quarter 2023 results: US$0.28 loss per share (down from US$0.011 profit in 3Q 2022). Revenue: US$6.64m (down 32% from 3Q 2022). Net loss: US$8.40m (down US$8.73m from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Apr 13
Insider recently bought €1.5m worth of stock On the 6th of April, Carlos Valadez bought around 2m shares on-market at roughly €0.95 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €1.6m more in shares than they have sold in the last 12 months. Reported Earnings • Feb 05
Second quarter 2023 earnings released: US$0.034 loss per share (vs US$0.039 profit in 2Q 2022) Second quarter 2023 results: US$0.034 loss per share (down from US$0.039 profit in 2Q 2022). Revenue: US$10.4m (down 25% from 2Q 2022). Net loss: US$1.04m (down 189% from profit in 2Q 2022). Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. 공시 • Jan 20
Charles & Colvard, Ltd. to Report Q2, 2023 Results on Feb 02, 2023 Charles & Colvard, Ltd. announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Feb 02, 2023 공시 • Dec 26
Charles & Colvard Receives A Notification Letter from Nasdaq Regarding Minimum Bid Price On December 19, 2022, Charles & Colvard, Ltd. ("the Company") received a notification letter from Nasdaq's Listing Qualifications Department indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the minimum bid price of its common stock on the Nasdaq Capital Market has closed below $1.00 per share for 30 consecutive business days. The notification letter has no immediate effect on the Nasdaq listing or trading in the Company's common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until June 19, 2023, to regain compliance with the minimum $1.00 bid price per share requirement. To regain compliance, any time before June 19, 2023, the bid price of the Company's common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. On June 19, 2023, if the Company’s meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except for the minimum bid price requirement), and the Company notifies Nasdaq of its intention to cure the deficiency, the Company may be provided with an additional 180 calendar day compliance period to regain compliance. If the Company is not eligible for an additional compliance period at that time, Nasdaq will provide the Company with written notification that its common stock will be subject to delisting. Upon such notice, the Company may appeal Nasdaq’s delisting determination to a Nasdaq hearing panel. There can be no assurance that, if the Company appeals Nasdaq’s determination, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the listing requirements. Reported Earnings • Nov 05
First quarter 2023 earnings released: US$0.029 loss per share (vs US$0.028 profit in 1Q 2022) First quarter 2023 results: US$0.029 loss per share (down from US$0.028 profit in 1Q 2022). Revenue: US$7.37m (down 28% from 1Q 2022). Net loss: US$890.2k (down 208% from profit in 1Q 2022). Revenue is forecast to stay flat during the next 2 years compared to a 7.3% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. 공시 • Oct 21
Charles & Colvard, Ltd. to Report Q1, 2023 Results on Nov 03, 2022 Charles & Colvard, Ltd. announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2022 공시 • Oct 07
Charles & Colvard Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New Color Charles & Colvard, Ltd. announced with three major launches unveiled in three months time, their latest announcement - new lab grown precious gemstones in color - is another big milestone for the company and adds a colorful new dimension to their already impressive Made, Not Mined™ fine jewelry repertoire. Featuring lab grown ruby, sapphire, and emerald gemstones, the new conscious color collection also includes Caydia lab grown diamonds and showcases the above-ground stones with artistic silhouettes and higher carat designs. With dynamic movement and bold pops of color, these new pieces showcase lab grown precious gemstones that are manmade and graded by certified GIA experts to meet their superior AAA quality. Besides the obvious benefits to mother earth, the growing of precious gemstones allows for the color to be highly curated and produces clarity and polish standards of an excellent grading. (Something mined gemstones can rarely tout.) Made for the fashion-forward woman who has no desire to blend in - these colorful new pieces are perfectly timed with a recent runway fashion appetite that Vogue and other fashion magazines have referred to as an "uncontainable maximalist" style. 공시 • Oct 01
Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022 Charles & Colvard, Ltd., Annual General Meeting, Nov 17, 2022, at 10:00 US Eastern Standard Time. Location: 170 Southport Drive, Morrisville North Carolina 27560 Carolina United States Agenda: To elect five nominees described in the proxy statement to the Board of Directors; to ratify the appointment of BDO USA, LLP as independent registered public accounting firm for the fiscal year ending June 30, 2023; to vote, on an advisory (nonbinding) basis, to approve executive compensation; and to transact such other business as may properly come before the meeting or any adjournment thereof. 공시 • Sep 16
Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's Bands Charles & Colvard, Ltd. announced Fresh off a Couture Collection launch that showcased their Caydia® lab grown diamonds in astounding carat weights and dramatic new silhouettes - Charles & Colvard is once again turning heads. This time, with their first ever line of men's diamond fashion bands. Featuring Caydia® lab grown diamonds and 14K recycled yellow and white gold, this sleek new line will join their acclaimed Signature Collection and give yet another glimpse into a bold and exciting new direction for the company already beloved for their Made, Not Mined™ bridal fine jewelry. While Charles & Colvard has no desire to slow down its contribution to wedding ring categories, it does plan to vastly expand its presence in the lab grown diamond fashion jewelry market. On a mission to become one of the elite destinations for lab grown diamond jewelry - these men's bands exemplify the brand's ability to marry traditional shapes with refined design. With staunch lines and mixed precious metals, these bands were engineered to balance traditional masculinity and modern sophistication. Bold and geometric, they command attention while remaining versatile and practical enough for everyday wear. Launched as part of the company's esteemed Signature Collection, each band features the company's patented signature star emblem inside the shank. Intended just for the wearer to know it's there – it's a powerful reminder to never compromise on standards. The company's commitment to using exclusively Made, Not Mined™ gemstones and 100% recycled precious metals is what sets them apart in the industry. While conscious bridal consumers have been aware of the brand since they began nearly 30 years ago, the Research Triangle Park, NC-based company won't be satisfied until their products are synonymous with all lab grown fine jewelry. Reported Earnings • Sep 03
Full year 2022 earnings released: EPS: US$0.078 (vs US$0.44 in FY 2021) Full year 2022 results: EPS: US$0.078 (down from US$0.44 in FY 2021). Revenue: US$43.1m (up 9.8% from FY 2021). Net income: US$2.37m (down 82% from FY 2021). Profit margin: 5.5% (down from 33% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 9.7% compared to a 13% growth forecast for the Luxury industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. 공시 • Aug 19
Charles & Colvard, Ltd. to Report Q4, 2022 Results on Sep 01, 2022 Charles & Colvard, Ltd. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Sep 01, 2022 공시 • Aug 18
Charles & Colvard Redefines Conscious Luxury with New Lab Grown Diamond Couture Collection A brand on the move, Charles & Colvard is giving the luxury industry a glimpse of what the future of fine jewelry looks like with their new Couture Collection. Responsibly crafted using Caydia® lab grown diamonds and recycled precious metals, the 50-piece collection features rings, bracelets, and earnings in staggering carat weights and design combinations that prove luxury fine jewelry can still be conscious. From 10-carat chandelier drop earrings, to double and triple stacked geometric eternity bands, and jaw-dropping 12- and 13-carat alternating tennis bracelets – the collection is intended for couture brides, red carpet fashion, celebrities, or anyone looking for high-carat conscious couture. Adding to their already-impressive repertoire of made, not mined™ fine jewelry – the company has their sights on becoming one of the top destinations for lab grown diamond jewelry. A stunning showcase of abstract silhouettes and dramatic lines that feature new pear, baguette, and marquise cuts, this collection certainly makes a case for why they should be. Their approach – using exclusively made, not mined gemstones – has been a popular choice that is gaining traction for nearly three decades. They've used that time to perfect their craftsmanship and now consider themselves an industry leader in the lab grown space. Building a fine jewelry company that's motivated by conscience, O'Connell says it's time the industry redefines what high couture jewelry looks like and where they're looking to buy it. 공시 • Jun 26
Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth Index Charles & Colvard, Ltd.(NasdaqCM:CTHR) dropped from Russell 3000E Growth Index Recent Insider Transactions • May 28
Independent Chairman recently bought €96k worth of stock On the 26th of May, Neal Goldman bought around 79k shares on-market at roughly €1.22 per share. This was the largest purchase by an insider in the last 3 months. Neal has been a buyer over the last 12 months, purchasing a net total of €103k worth in shares. Reported Earnings • May 06
Third quarter 2022 earnings released: EPS: US$0.011 (vs US$0.035 in 3Q 2021) Third quarter 2022 results: EPS: US$0.011 (down from US$0.035 in 3Q 2021). Revenue: US$9.75m (up 3.3% from 3Q 2021). Net income: US$338.5k (down 67% from 3Q 2021). Profit margin: 3.5% (down from 11% in 3Q 2021). Over the next year, revenue is forecast to grow 7.4%, compared to a 13% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. 공시 • May 06
Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces an Equity Buyback for $5 million worth of its shares. Charles & Colvard, Ltd. (NasdaqCM:CTHR) announces a share repurchase program. Under the program, the company will repurchase up to $5 million worth of its shares. The program will be funded by cash on hand and cash generated by operations. The program will expire on April 29, 2025. 공시 • Apr 22
Charles & Colvard, Ltd. to Report Q3, 2022 Results on May 05, 2022 Charles & Colvard, Ltd. announced that they will report Q3, 2022 results Pre-Market on May 05, 2022 Reported Earnings • Feb 04
Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Second quarter 2022 results: EPS: US$0.039 (down from US$0.087 in 2Q 2021). Revenue: US$13.8m (up 13% from 2Q 2021). Net income: US$1.17m (down 54% from 2Q 2021). Profit margin: 8.5% (down from 21% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 5.6%, compared to a 5.2% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 09
First quarter 2022 earnings released: EPS US$0.028 (vs US$0.03 in 1Q 2021) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: US$10.3m (up 30% from 1Q 2021). Net income: US$827.0k (down 5.4% from 1Q 2021). Profit margin: 8.0% (down from 11% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 51% per year. Reported Earnings • Sep 07
Full year 2021 earnings released: EPS US$0.44 (vs US$0.21 loss in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: US$39.2m (up 34% from FY 2020). Net income: US$12.8m (up US$19.0m from FY 2020). Profit margin: 33% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 25
Investor sentiment improved over the past week After last week's 19% share price gain to US$2.66, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Luxury industry in Europe. Total returns to shareholders of 198% over the past three years. Is New 90 Day High Low • Mar 03
New 90-day high: €2.10 The company is up 118% from its price of €0.96 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 8.0% over the same period. Is New 90 Day High Low • Feb 10
New 90-day high: €1.95 The company is up 122% from its price of €0.88 on 11 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 1.0% over the same period. Reported Earnings • Feb 06
Second quarter 2021 earnings released: EPS US$0.087 (vs US$0.028 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$12.1m (up 14% from 2Q 2020). Net income: US$2.52m (up 209% from 2Q 2020). Profit margin: 21% (up from 7.6% in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Feb 06
Revenue beats expectations Revenue exceeded analyst estimates by 7.5%. Over the next year, revenue is forecast to grow 16%, compared to a 10% growth forecast for the Luxury industry in Germany. 공시 • Jan 22
Charles & Colvard, Ltd. to Report Q2, 2021 Results on Feb 04, 2021 Charles & Colvard, Ltd. announced that they will report Q2, 2021 results After-Market on Feb 04, 2021 Is New 90 Day High Low • Jan 19
New 90-day high: €1.11 The company is up 53% from its price of €0.72 on 21 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 6.0% over the same period. Is New 90 Day High Low • Dec 11
New 90-day high: €1.04 The company is up 82% from its price of €0.57 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 8.0% over the same period. 공시 • Dec 04
Charles & Colvard Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement Charles & Colvard, Ltd. announced that it has regained compliance with Nasdaq's minimum bid price continued listing requirement. A letter from the Nasdaq Listing Qualifications Department noted that as of November 27, 2020, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business days. Therefore, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed. Recent Insider Transactions • Nov 19
Independent Director recently bought €75k worth of stock On the 12th of November, Ollin Sykes bought around 87k shares on-market at roughly €0.86 per share. In the last 3 months, they made an even bigger purchase worth €115k. Insiders have collectively bought €256k more in shares than they have sold in the last 12 months. Analyst Estimate Surprise Post Earnings • Nov 07
Revenue beats expectations Revenue exceeded analyst estimates by 39%. Over the next year, revenue is expected to shrink by 5.9% compared to a 6.6% growth forecast for the Luxury industry in Germany. Reported Earnings • Nov 07
First quarter 2021 earnings released: EPS US$0.03 The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$7.93m (up 4.2% from 1Q 2020). Net income: US$874.3k (up 322% from 1Q 2020). Profit margin: 11% (up from 2.7% in 1Q 2020). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Nov 07
New 90-day high: €0.83 The company is up 42% from its price of €0.59 on 07 August 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 12% over the same period. Is New 90 Day High Low • Oct 07
New 90-day high: €0.80 The company is up 34% from its price of €0.59 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Luxury industry, which is up 15% over the same period. Recent Insider Transactions • Sep 19
Independent Director recently bought €115k worth of stock On the 16th of September, Ollin Sykes bought around 177k shares on-market at roughly €0.65 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €177k more in shares than they have sold in the last 12 months. 공시 • Aug 21
Charles & Colvard, Ltd. to Report Q4, 2020 Results on Sep 03, 2020 Charles & Colvard, Ltd. announced that they will report Q4, 2020 results at 5:00 PM, Eastern Standard Time on Sep 03, 2020 